- sales@materia-uk.com
- T: TBA
Materia Deutschland GmbH Our name, inspired by materia medica, stands for the connection of nature and knowledge.
Materia is a pharmaceutical distributor specialising in high quality medical cannabis products, manufactured by EU-GMP certified partners and distributed under GDP guidelines. Founded in Hamburg in June 2018, Materia Deutschland GmbH supplies pharmacies and wholesalers with cannabis flowers, cannabis extracts and dronabinol, and now serves the UK through Materia UK.
Materia is a supporting member of the German Association of Cannabis-Supplying Pharmacies (VCA). The goal of the VCA is to provide efficient and affordable access to medicinal cannabis for patients.
Add short BIO about the founders and MD and their experience.
Our Mission
Our mission is to improve access to high-quality cannabinoid medicines while supporting the healthcare professionals who rely on them.
We do this by combining pharmaceutical standards with scientific expertise and practical collaboration. Our goal is not only to supply products, but to help create a more informed, dependable, and professionally supported environment around cannabinoid medicine.
Built on proven experience. Focused on the future.
Materia UK represents the next step in our international growth, built on years of experience established by the wider Materia group in Germany. Since entering the German medical cannabis market in 2018, Materia has focused on one clear objective: supporting healthcare professionals with reliable pharmaceutical products, scientific expertise and trusted partnerships.
Today, Materia works closely with pharmacies, clinicians, manufacturers and industry partners to improve access to high quality cannabinoid medicines through education, collaboration and pharmaceutical excellence. As we expand internationally, these same principles guide everything we do.
Education has always been central to Materia’s work.
Medical cannabis continues to evolve, and healthcare professionals need clear, evidence-based information to make informed decisions. Over the years, Materia has supported educational events, expert discussions, and practical resources designed to bring together clinicians, pharmacists, and researchers.
Our educational approach is focused on usefulness. We aim to make scientific information easier to access, easier to understand, and easier to apply in practice. Through this work, we help strengthen confidence in cannabinoid medicine and support better conversations around patient care.
Our portfolio is built with a clear principle in mind: quality matters more than quantity.
Rather than offering the widest possible range, Materia focuses on carefully selected cannabinoid medicines that meet high standards of pharmaceutical quality, reliability of supply, and clinical relevance. We work with partners who share our commitment to consistency and professionalism.
As our international activities continue to grow, we remain focused on building a portfolio that is dependable, relevant, and aligned with the needs of healthcare professionals and patients.
We see a future in which cannabinoid medicine is supported by stronger evidence, better education, and more collaborative partnerships across the healthcare system.
Materia UK is part of that future. Our ambition is to become a trusted pharmaceutical partner for healthcare professionals, pharmacies, and organisations working in this field. We will continue to grow carefully, guided by the same principles that have shaped our work from the start: pharmaceutical quality, scientific integrity, meaningful partnerships, and continuous education.
Everything we do is guided by a small number of clear values.
Pharmaceutical quality
Reliability
Scientific integrity
Education
Partnership
Responsibility
These values are not just words. They shape our standards, our relationships, and our long-term approach to growth.
Built on the experience of Materia Deutschland. Expanding internationally through Materia UK.